Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-02

FDA Approved: ACARBOSE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for acarbose submitted by Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acarbose (acarbose)

Snippet

SUPPL AP for ACARBOSE (ACARBOSE)